dexmedetomidin is one of 37 small molecule programs targeting Dexmedetomidine. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
30 competitors in Anesthesia
Precedex
Versed
Sufenta
Iheezo
Xylocaine
Ultiva
Duragesic
Romazicon
Ultram
Magnesium
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details